199 related articles for article (PubMed ID: 36636995)
1. Multivalent Lactobionic Acid and N-Acetylgalactosamine-Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes.
Kumar V; Wahane A; Gupta A; Manautou JE; Bahal R
Adv Healthc Mater; 2023 May; 12(12):e2202859. PubMed ID: 36636995
[TBL] [Abstract][Full Text] [Related]
2. Receptor-Specific Delivery of Peptide Nucleic Acids Conjugated to Three Sequentially Linked
Bhingardeve P; Madhanagopal BR; Naick H; Jain P; Manoharan M; Ganesh K
J Org Chem; 2020 Jul; 85(14):8812-8824. PubMed ID: 32529829
[TBL] [Abstract][Full Text] [Related]
3. A universal discoidal nanoplatform for the intracellular delivery of PNAs.
Tahmasbi Rad A; Malik S; Yang L; Oberoi-Khanuja TK; Nieh MP; Bahal R
Nanoscale; 2019 Jul; 11(26):12517-12529. PubMed ID: 31188378
[TBL] [Abstract][Full Text] [Related]
4. Nuclear localization and antisense effect of PNA internalized by ASGP-R-mediated endocytosis with protein/DNA conjugates.
Ishihara T; Kano A; Obara K; Saito M; Chen X; Park TG; Akaike T; Maruyama A
J Control Release; 2011 Oct; 155(1):34-9. PubMed ID: 20955741
[TBL] [Abstract][Full Text] [Related]
5. Preparation of Anti-miR PNAs for Drug Development and Nanomedicine.
Manicardi A; Gambari R; de Cola L; Corradini R
Methods Mol Biol; 2018; 1811():49-63. PubMed ID: 29926445
[TBL] [Abstract][Full Text] [Related]
6. Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide conjugates.
Kaihatsu K; Huffman KE; Corey DR
Biochemistry; 2004 Nov; 43(45):14340-7. PubMed ID: 15533038
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the biological activity of microRNA-210 with peptide nucleic acids (PNAs).
Fabbri E; Manicardi A; Tedeschi T; Sforza S; Bianchi N; Brognara E; Finotti A; Breveglieri G; Borgatti M; Corradini R; Marchelli R; Gambari R
ChemMedChem; 2011 Dec; 6(12):2192-202. PubMed ID: 22012891
[TBL] [Abstract][Full Text] [Related]
8. Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers.
Gambari R
Curr Pharm Des; 2001 Nov; 7(17):1839-62. PubMed ID: 11562312
[TBL] [Abstract][Full Text] [Related]
9. Pretargeting with amplification using polymeric peptide nucleic acid.
Wang Y; Chang F; Zhang Y; Liu N; Liu G; Gupta S; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2001; 12(5):807-16. PubMed ID: 11562199
[TBL] [Abstract][Full Text] [Related]
10. miR-7 Knockdown by Peptide Nucleic Acids in the Ascidian
Mercurio S; Cauteruccio S; Manenti R; Candiani S; Scarì G; Licandro E; Pennati R
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623150
[TBL] [Abstract][Full Text] [Related]
11. Delivery of Peptide Nucleic Acids Using an Argininocalix[4]arene as Vector.
Finotti A; Gasparello J; Casnati A; Corradini R; Gambari R; Sansone F
Methods Mol Biol; 2021; 2211():123-143. PubMed ID: 33336275
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptakes, biostabilities and anti-miR-210 activities of chiral arginine-PNAs in leukaemic K562 cells.
Manicardi A; Fabbri E; Tedeschi T; Sforza S; Bianchi N; Brognara E; Gambari R; Marchelli R; Corradini R
Chembiochem; 2012 Jun; 13(9):1327-37. PubMed ID: 22639449
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length.
Doyle DF; Braasch DA; Simmons CG; Janowski BA; Corey DR
Biochemistry; 2001 Jan; 40(1):53-64. PubMed ID: 11141056
[TBL] [Abstract][Full Text] [Related]
14. Peptide nucleic acid conjugates: synthesis, properties and applications.
Zhilina ZV; Ziemba AJ; Ebbinghaus SW
Curr Top Med Chem; 2005; 5(12):1119-31. PubMed ID: 16248787
[TBL] [Abstract][Full Text] [Related]
15. Extending recognition by peptide nucleic acids (PNAs): binding to duplex DNA and inhibition of transcription by tail-clamp PNA-peptide conjugates.
Kaihatsu K; Shah RH; Zhao X; Corey DR
Biochemistry; 2003 Dec; 42(47):13996-4003. PubMed ID: 14636068
[TBL] [Abstract][Full Text] [Related]
16. Protein/oligonucleotide conjugates as a cell specific PNA carrier.
Obara K; Ishihara T; Akaike T; Maruyama A
Nucleic Acids Res Suppl; 2001; (1):217-8. PubMed ID: 12836342
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy.
Dhuri K; Gaddam RR; Vikram A; Slack FJ; Bahal R
Cancer Res; 2021 Nov; 81(22):5613-5624. PubMed ID: 34548334
[TBL] [Abstract][Full Text] [Related]
18. Sequence-specific DNA strand cleavage by 111In-labeled peptide nucleic acids.
He Y; Panyutin IG; Karavanov A; Demidov VV; Neumann RD
Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):837-45. PubMed ID: 14762696
[TBL] [Abstract][Full Text] [Related]
19. Poly(Lactic-co-Glycolic Acid) Nanoparticle Delivery of Peptide Nucleic Acids In Vivo.
Oyaghire SN; Quijano E; Piotrowski-Daspit AS; Saltzman WM; Glazer PM
Methods Mol Biol; 2020; 2105():261-281. PubMed ID: 32088877
[TBL] [Abstract][Full Text] [Related]
20. Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents.
Torres AG; Threlfall RN; Gait MJ
Artif DNA PNA XNA; 2011; 2(3):71-8. PubMed ID: 22567190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
